Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $60.36 ($2.4M) on 2018-08-20, disclosed to the SEC on 2018-08-22.
Scheduled sale ($2.4M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.82 | 918 | $55K | 2.3% |
| 2 | $59.83 | 14,897 | $891K | 37.3% |
| 3 | $60.36 | 4,003 | $242K | 10.1% |
| 4 | $60.00 | 4,365 | $262K | 11.0% |
| 5 | $60.59 | 918 | $56K | 2.3% |
| 6 | $60.71 | 14,535 |
| $882K |
| 37.0% |
| Total | $60.24 avg | 39,636 | $2.4M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |